Viewing Protocol Section

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT00074165
Ignite Creation Date: 2024-05-05 @ 11:33 AM
Last Modification Date: 2025-12-17 @ 3:47 AM
Study NCT ID: NCT00074165
Protocol Section: NCT00074165
Start Identification Module Data
Expand Identification Module Data
Brief Title: Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen
Official Title: A Phase II Trial Involving Patients With Recurrent PCNSL Treated With Carboplatin/BBBD, by Adding Rituxan (Rituximab), An Anti CD-20 Antibody, To The Treatment Regimen
Acronym: None
Organization: OHSU Knight Cancer Institute
Organization Class: OTHER
Organization Study ID: IRB00000641
Secondary IDs
Secondary ID Type Domain Link
5R01CA137488-15 NIH None None
ONC-02059-LX OTHER None None
641 OTHER None None
7465 OTHER None None
OHSU-641 OTHER OHSU IRB httpsreporternihgovquickSearch5R01CA137488-15
Start Status Module Data
Status Verified Date: 2023-06
Overall Status: None
Study First Submit Date: 2003-12-10
Study First Submit QC Date:
Last Update Submit Date: 2023-06-21
Status: TERMINATED
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: OHSU Knight Cancer Institute
Lead Sponsor Class: OTHER
Lead Sponsor: OHSU Knight Cancer Institute
Start Oversight Module Data 7501
Description Module: 10291
Study Last Update Post Date Type(Status Module):
Attachment: Upload